UBS AM Portfolio holdings
UBS Asset Management (UBS AM), a division of UBS Group AG with origins tied to the bank’s founding in 1862, is headquartered in Zurich, Switzerland, and manages hundreds of billions in assets for institutional, intermediary, and wealth management clients globally. Specializing in a broad range of investment strategies—including equities, fixed income, multi-asset, alternatives, and sustainable investing—UBS AM leverages the firm’s extensive research capabilities and global network to deliver tailored solutions. Known for its focus on risk management and innovation, it offers products like ETFs, index funds, and private market investments, catering to diverse needs from pension funds to high-net-worth individuals. As part of UBS’s broader ecosystem, UBS AM combines Swiss precision with a commitment to ESG principles, solidifying its position as a leader in the asset management industry.
Top Buys
| 1 |
Accenture
ACN
|
$412M |
| 2 |
iShares Core S&P Total US Stock Market ETF
ITOT
|
$324M |
| 3 |
iShares Core S&P Small-Cap ETF
IJR
|
$310M |
| 4 |
ConocoPhillips
COP
|
$262M |
| 5 |
iShares Core MSCI EAFE ETF
IEFA
|
$237M |
Top Sells
| 1 |
Apple
AAPL
|
$1.78B |
| 2 |
Alphabet (Google) Class A
GOOGL
|
$326M |
| 3 |
Microsoft
MSFT
|
$258M |
| 4 |
Alphabet (Google) Class C
GOOG
|
$206M |
| 5 |
UnitedHealth
UNH
|
$198M |
Sector Composition
| 1 | Technology | 25.86% |
| 2 | Healthcare | 14.95% |
| 3 | Financials | 12.09% |
| 4 | Consumer Discretionary | 10.74% |
| 5 | Communication Services | 7.21% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
2526
Allegiant Air
ALGT
$1.18B
| $219K | ﹤0.01% |
3,003
-2,475
| -45% | -$181K |
|
|
DX
2527
Dynex Capital
DX
$1.68B
| $219K | ﹤0.01% |
18,811
-2,178
| -10% | -$25.4K |
|
2528
Perella Weinberg Partners
PWP
$1.39B
| $218K | ﹤0.01% |
34,400
| – | – |
|
2529
Tejon Ranch
TRC
$446M
| $217K | ﹤0.01% |
15,069
-12,799
| -46% | -$184K |
|
2530
4D Molecular Therapeutics
FDMT
$340M
| $216K | ﹤0.01% |
26,894
+13,712
| +104% | +$110K |
|
2531
Energy Vault
NRGV
$335M
| $216K | ﹤0.01% |
40,874
| – | – |
|
2532
Koppers
KOP
$569M
| $214K | ﹤0.01% |
+10,291
| New | +$214K |
|
|
DMTK
2533
DELISTED
DermTech, Inc. Common Stock
DMTK
| $213K | ﹤0.01% |
53,872
+8,430
| +19% | +$33.4K |
|
|
AD
2534
Array Digital Infrastructure, Inc.
AD
$4.54B
| $213K | ﹤0.01% |
8,179
+593
| +8% | +$15.4K |
|
|
MAGN
2535
Magnera Corporation
MAGN
$428M
| $213K | ﹤0.01% |
5,263
| – | – |
|
2536
National Presto Industries
NPK
$782M
| $212K | ﹤0.01% |
3,258
| – | – |
|
2537
IDT Corp
IDT
$1.64B
| $211K | ﹤0.01% |
+8,496
| New | +$211K |
|
2538
DXP Enterprises
DXPE
$1.95B
| $211K | ﹤0.01% |
8,900
| – | – |
|
2539
Latham Group
SWIM
$960M
| $210K | ﹤0.01% |
58,540
| – | – |
|
2540
Anika Therapeutics
ANIK
$129M
| $210K | ﹤0.01% |
8,829
-1,580
| -15% | -$37.6K |
|
2541
Nomad Foods
NOMD
$2.21B
| $210K | ﹤0.01% |
+14,760
| New | +$210K |
|
|
AGTI
2542
DELISTED
Agiliti, Inc.
AGTI
| $209K | ﹤0.01% |
14,602
+2,702
| +23% | +$38.7K |
|
2543
Atlanta Braves Holdings Series A
BATRA
$2.86B
| $209K | ﹤0.01% |
+7,421
| New | +$209K |
|
2544
ANI Pharmaceuticals
ANIP
$2.07B
| $208K | ﹤0.01% |
6,485
-1,638
| -20% | -$52.6K |
|
2545
Immunovant
IMVT
$2.99B
| $208K | ﹤0.01% |
37,345
-14,597
| -28% | -$81.5K |
|
2546
Forrester Research
FORR
$187M
| $208K | ﹤0.01% |
5,776
-6,461
| -53% | -$233K |
|
2547
First Mid Bancshares
FMBH
$963M
| $208K | ﹤0.01% |
6,503
-1,469
| -18% | -$47K |
|
|
WW
2548
DELISTED
WW International
WW
| $207K | ﹤0.01% |
52,633
-11,225
| -18% | -$44.1K |
|
2549
TrueCar
TRUE
$191M
| $207K | ﹤0.01% |
136,907
| – | – |
|
|
EGRX
2550
DELISTED
Eagle Pharmaceuticals, Inc.
EGRX
| $206K | ﹤0.01% |
7,799
-5,143
| -40% | -$136K |
|